中国生物制药
01177 · HK
01177 Research Preview
| Field | Reading |
|---|---|
| Price | HKD 4.58 |
| Daily move | -0.43% |
| Day high / low | 4.71 / 4.50 |
| Volume | 89,115,859 |
| Strategy score | 50/100 (Hold) |
| Trend | Consolidation |
| RSI | N/A |
| MACD | N/A |
| Support | N/A |
| Resistance | N/A |
| 30-session range position | N/A |
| Data confidence | Low (technical) / Medium (valuation) |
| Indicator | Reading | State |
|---|---|---|
| MA5 / MA10 / MA20 / MA60 | N/A | Insufficient moving-average data |
| RSI14 / RSI6 | N/A | RSI14 unavailable |
| MACD line / signal / histogram | N/A | MACD unavailable |
| KDJ K / D / J | N/A | KDJ unavailable |
| Bollinger upper / middle / lower | N/A | Bollinger position unavailable |
| ATR14 / ATR14% | N/A | ATR unavailable |
| OBV / OBV 20-session slope | N/A | OBV unavailable |
| CCI20 | N/A | CCI unavailable |
What is confirmed: Nothing on the technical layer can be confirmed. The only directly observable price facts are the last price (4.58), the intraday range (4.50-4.71), the daily move (-0.43%), and session volume (89.1M shares).
What is conflicted: No genuine conflict can be assessed, since no two indicators are available to compare. The component strategy scores (MA交叉, MACD背离, RSI极值, 布林带, 量价关系) all sit at a neutral 50/100 specifically because of insufficient data, not because of balanced bullish/bearish signals.
What is missing: The entire trend, momentum, volatility, and volume-flow toolkit. Without moving averages there is no trend structure; without RSI/KDJ/CCI there is no momentum or extreme read; without MACD there is no trend-momentum confirmation; without Bollinger or ATR there is no volatility framing; without OBV there is no volume-flow read. No custom indicators were supplied.
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 36.67 | AkShare Eastmoney HK financial indicators | Medium |
| PB | 2.79 | AkShare Eastmoney HK financial indicators | Medium |
| StockKit fair value range | Bear HKD 1.15 / Base HKD 1.46 / Bull HKD 1.89 | StockKit DCF scenario model (internally computed, not consensus) | Medium |
| Base fair-value gap | -68.2% | StockKit DCF scenario model (internally computed) | Medium |
| 5Y growth forecast | Bear -8.00% / Base -2.70% / Bull +3.30% | StockKit scenario model (internally computed) | Medium |
| Operating income | HKD 31.83B | AkShare Eastmoney HK financial indicators | Medium |
| Holder profit | HKD 2.34B | AkShare Eastmoney HK financial indicators | Medium |
| EPS TTM | 0.12 | AkShare Eastmoney HK financial indicators | Medium |
| Book value per share | 1.64 | AkShare Eastmoney HK financial indicators | Medium |
| Gross margin | +82.07% | AkShare Eastmoney HK financial indicators | Medium |
| Net margin | +16.69% | AkShare Eastmoney HK financial indicators | Medium |
The fundamental snapshot (report period 2025-12-31) shows a high gross margin of +82.07% alongside a +16.69% net margin, with HKD 31.83B operating income and HKD 2.34B holder profit. At HKD 4.58 the PE of 36.67 against EPS TTM of 0.12, and PB of 2.79 against book value per share of 1.64, both reflect a premium to trailing fundamentals. The most striking item is the StockKit DCF base fair value of HKD 1.46, a -68.2% gap to the current price. This is an internally computed scenario output, not an analyst consensus target, and it is paired with a soft 5Y growth forecast (base -2.70%). The large negative gap should be read as a model signal to examine the underlying growth and discount-rate assumptions rather than as a price call. PEG proxy and EV/EBITDA were not supplied and are omitted.
| Item | Status |
|---|---|
| Configured news source | No current news items available |
Confirmed news: None. No headlines were returned from the configured source for this symbol in the supplied dataset.
Missing data: The entire news and catalyst layer is absent. Without confirmed headlines there are no earnings dates, regulatory updates, pipeline events, or corporate actions to anchor a catalyst timeline. No catalysts are inferred or invented. This is a meaningful gap for a pharmaceutical issuer, where pipeline and regulatory news typically drive price action.
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | No headlines | No source distribution available | Low |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
No provider sentiment series was returned for this symbol. Headline coverage produced no source distribution, and the social sentiment channel is not connected, so no Reddit, X, StockTwits, or local-forum readings are drawn. The sentiment layer is effectively dark and should not be used to support any directional view.
| Scenario | Trigger conditions | What would confirm it | What would invalidate it |
|---|---|---|---|
| Base | Price continues to oscillate around current levels; strategy score holds near 50/100 in consolidation | Restored technical data showing flat MA structure and neutral RSI/MACD; price holding inside the 4.50-4.71 zone | A decisive break with volume above or below the intraday range once indicators are available |
| Upside | Price reclaims and holds above the session high of 4.71 on expanding volume relative to its average | Confirmed positive momentum once RSI/MACD restore; fundamental support from the +82.07% gross margin and HKD 2.34B holder profit | Failure to hold above 4.71; volume fading back toward the lower end of the range |
| Downside | Price loses the session low of 4.50; renewed attention to the -68.2% base fair-value gap | Restored indicators turning down together; weak follow-through after losing 4.50 | Price stabilizing above 4.50 and the strategy score lifting off the neutral 50/100 floor |
All watch levels above are observational reference points derived from the supplied intraday range (4.50-4.71) and the strategy score, not instructions to act.
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Technical blind spot | Every indicator (MA, RSI, MACD, KDJ, Bollinger, ATR, OBV, CCI) is N/A; score components all 50/100 on insufficient data | Continued absence of indicator data | Watch for restored indicator feeds before drawing any trend or momentum conclusion |
| Large fair-value gap | StockKit DCF base HKD 1.46 vs price 4.58, a -68.2% gap | Gap persisting or widening as fundamentals update | Review the DCF growth (base -2.70%) and discount assumptions driving the gap |
| Soft growth outlook | 5Y growth forecast base -2.70%, bear -8.00% | Confirmation of declining growth in future filings | Track operating income (HKD 31.83B) and holder profit (HKD 2.34B) trend across periods |
| Information vacuum | No news and no sentiment data returned | A material event occurring without coverage in the feed | Monitor for restored news/sentiment connectivity; treat absence as unknown, not as calm |
| Valuation premium | PE 36.67 and PB 2.79 against EPS TTM 0.12 and BVPS 1.64 | Earnings disappointment that does not justify the premium | Compare future EPS against the trailing 0.12 base |
数据不足
数据不足
数据不足
数据不足
数据不足
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.